Mannitol in intracerebral hemorrhage: a randomized controlled study

Misra, U. K. ; Kalita, J. ; Ranjan, P. ; Mandal, S. K. (2005) Mannitol in intracerebral hemorrhage: a randomized controlled study Journal of the Neurological Sciences, 234 (1). pp. 41-45. ISSN 0022-510X

Full text not available from this repository.

Official URL: http://linkinghub.elsevier.com/retrieve/pii/S00225...

Related URL: http://dx.doi.org/10.1016/j.jns.2005.03.038

Abstract

Objective: To study the usefulness of mannitol in spontaneous intracerebral hemorrhage (ICH) patients. Method: 128 CT proven supratentorial ICH patients within 6 days of ictus were randomized into study and control groups. The study group received mannitol 20%, 100 ml every 4 h for 5 days, tapered in the next 2 days. The control group received sham infusion. Primary endpoint was 1-month mortality and secondary endpoint functional disability at 3 months assessed by Barthel index score. Results: There were 65 patients in study and 63 in control groups. The study and control groups were evenly matched regarding age, Glasgow coma scale (GCS) score, Canadian Neurological Scale (CNS) score, pupillary asymmetry, pyramidal signs on non-hemiplegic side, and location, midline shift and ventricular extension of hematoma. At 1 month, 16 patients died in each group. The primary and secondary endpoints were not significantly different between the two groups. Conclusion: Low dose mannitol does not seem to be beneficial in patients with ICH.

Item Type:Article
Source:Copyright of this article belongs to World Federation of Neurology.
Keywords:Stroke; Intracerebral Hemorrhage; Mannitol; Outcome; Prognosis; Randomized Study
ID Code:19820
Deposited On:22 Nov 2010 11:51
Last Modified:11 Jun 2011 09:17

Repository Staff Only: item control page